On the evening of January 9, Chongqing Sansheng Industrial Co., Ltd. (ST Sansheng 002742), which is mainly engaged in concrete and medicine, issued the Draft Pre-Restructuring Agreement and Restructuring Plan, which will strip concrete assets, retain the existing Chongqing Chunrui Pharmaceutical Co., Ltd. and Jilin Liaoyuan Baikang Co., Ltd., and timely inject the new owner Jiheng Group into Hebei Jiheng Pharmaceutical Co., Ltd.
On the evening of January
9, Chongqing Sansheng Industrial Co., Ltd. (ST Sansheng 002742), which is mainly engaged in concrete and medicine, issued the Draft Pre-Restructuring Agreement and Restructuring Plan, which will strip concrete assets, retain the existing Chongqing Chunrui Pharmaceutical Co., Ltd. and Jilin Liaoyuan Baikang Co., Ltd., and timely inject the new owner Jiheng Group into Hebei Jiheng Pharmaceutical Co., Ltd. Screenshot

from the announcement